Clinical characteristics | Conventional group | NACT group | |||||||
---|---|---|---|---|---|---|---|---|---|
SCC antigen | ISCC | SSCC | OSCC | FSCC | TSCC | FSCC (%) | TSCC (%) | ||
Age | Spearman CC | 0.204 | 0.064 | 0.095 | 0.134 | 0.073 | 0.037 | 0.102 | 0.057 |
P value | 0.220 | 0.616 | 0.457 | 0.295 | 0.565 | 0.774 | 0.421 | 0.655 | |
Tumor differentiation degree | Spearman CC | 0.076 | 0.111 | 0.195 | 0.117 | 0.109 | 0.158 | −0.016 | 0.126 |
P value | 0.644 | 0.381 | 0.123 | 0.359 | 0.389 | 0.212 | 0.903 | 0.323 | |
Number of positive lymph nodes | Spearman CC | 0.673 | 0.326 | 0.436 | 0.395 | 0.237 | 0.274 | 0.060 | 0.089 |
P value | < 0.001 | 0.009 | < 0.001 | 0.001 | 0.059 | 0.029 | 0.637 | 0.484 | |
Maximum length of the lesion before chemotherapy | Spearman CC | 0.643 | 0.352 | 0.217 | 0.212 | 0.429 | 0.402 | 0.383 | 0.283 |
P value | < 0.001 | 0.004 | 0.085 | 0.096 | < 0.001 | 0.001 | 0.002 | 0.023 | |
Maximum length of the lesion after chemotherapy | Spearman CC | – | 0.046 | 0.142 | 0.183 | 0.019 | 0.040 | −0.020 | −0.075 |
P value | – | 0.718 | 0.263 | 0.151 | 0.880 | 0.754 | 0.874 | 0.558 | |
Narrowing extent of the lesion | Spearman CC | – | 0.326 | 0.083 | 0.003 | 0.413 | 0.391 | 0.387 | 0.424 |
P value | – | 0.008 | 0.515 | 0.980 | 0.001 | 0.001 | 0.002 | <0.001 | |
Survival time | Spearman CC | −0.060 | −0.154 | −0.263 | −0.265 | −0.086 | − 0.030 | 0.033 | 0.111 |
P value | 0.716 | .0.227 | 0.037 | 0.037 | 0.502 | 0.816 | 0.800 | 0.387 |